摘要
本文总结了不同的靶标,如5α-还原酶,17β-羟化类固醇脱氢酶,7α-羟化酶,雄激素受体和蛋白激酶A对前列腺癌和良性前列腺增生的治疗的重要性。众所周知,双氢睾酮(DHT)与雄激素依赖性疾病的发展有关。目前,一些研究小组正在尝试开发新的甾体类和非甾体分子为了抑制DHT合成和生物反应。本文还讨论了文献报道中有关于描述新化合物的潜在治疗以及主要抑制5α-还原酶的新药的最新研究。
关键词: 良性前列腺增生,前列腺癌,5-α还原酶,17β-羟基类固醇脱氢酶,蛋白激酶A,雄激素受体,脱氢表雄酮衍生物,非渗透性睾酮结合物,G蛋白,蛋白激酶A
Current Medicinal Chemistry
Title:Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
Volume: 23 Issue: 8
Author(s): Marisa Cabeza, Araceli Sánchez-Márquez, Mariana Garrido, Aylín Silva and Eugene Bratoeff
Affiliation:
关键词: 良性前列腺增生,前列腺癌,5-α还原酶,17β-羟基类固醇脱氢酶,蛋白激酶A,雄激素受体,脱氢表雄酮衍生物,非渗透性睾酮结合物,G蛋白,蛋白激酶A
摘要: This article summarizes the importance of different targets such as 5α-reductase, 17β-HSD, CYP17A, androgen receptor and protein kinase A for the treatment of prostate cancer and benign prostatic hyperplasia. It is a well known fact that dihydrotestosterone (DHT) is associated with the development of androgen-dependent afflictions. At the present time, several research groups are attempting to develop new steroidal and non-steroidal molecules with the purpose of inhibiting the synthesis and biological response of DHT. This review also discusses the most recent studies reported in the literature that describe the therapeutic potential of novel compounds, as well as the new drugs, principally inhibitors of 5α-reductase.
Export Options
About this article
Cite this article as:
Marisa Cabeza, Araceli Sánchez-Márquez, Mariana Garrido, Aylín Silva and Eugene Bratoeff , Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases, Current Medicinal Chemistry 2016; 23 (8) . https://dx.doi.org/10.2174/0929867323666160210125642
DOI https://dx.doi.org/10.2174/0929867323666160210125642 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Indoor Dust Levels of Perfluoroalkyl Substances (PFASs) and the Role of Ingestion as an Exposure Pathway: A Review
Current Organic Chemistry Protein-Modified Magnetic Nanoparticles for Biomedical Applications
Current Organic Chemistry MicroRNAs in Tumorigenesis
Current Pharmaceutical Biotechnology Gallium-68 in Medical Imaging
Current Radiopharmaceuticals The Chromogranin A-Derived Vasostatins: New Players in the Endocrine Heart
Current Medicinal Chemistry Recent Advances in the Membrane Receptor Initiated Vitamin D Signaling of Calcium and Phosphate Transport Across Intestinal and Kidney Epithelia
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Non-invasive Biodiversified Sensors: A Modernized Screening Technology for Cancer
Current Pharmaceutical Design CypA: A Potential Target of Tumor Radiotherapy and/or Chemotherapy
Current Medicinal Chemistry Antisense Technology: A Selective Tool for Gene Expression Regulation and Gene Targeting
Current Pharmaceutical Biotechnology Therapeutic Targeting of TRP Channels - The TR(i)P to Pain Relief
Current Topics in Medicinal Chemistry Molecular Imaging of Breast Cancer: Role of RGD Peptides
Mini-Reviews in Medicinal Chemistry The Vitamin D Neuroendocrine System as a Target for Novel Neurotropic Drugs
CNS & Neurological Disorders - Drug Targets Molecular Mechanisms Regulating Matrix Metalloproteinases
Current Topics in Medicinal Chemistry Clinical Pharmacogenetics and Potential Application in Personalized Medicine
Current Drug Metabolism Role of the Receptor Tyrosine Kinase Axl and its Targeting in Cancer Cells
Current Medicinal Chemistry HSF1, A Versatile Factor in Tumorogenesis
Current Molecular Medicine Chalcones as Promising Lead Compounds on Cancer Therapy
Current Medicinal Chemistry Doxorubicin-Loaded Nanoparticles: New Advances in Breast Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Modulators of Voltage-Dependent Calcium Channels for the Treatment of Nervous System Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Signal Transduction Pathways of Taxanes-Induced Apoptosis
Current Medicinal Chemistry - Anti-Cancer Agents